心血管医学における交差点:進歩と効果への障壁
Jessica A Regan1,2, Melissa H Laitner3, Victor J Dzau1,3,4
1Division of Cardiology (J.A.R., V.J.D.), Duke University School of Medicine, Durham, NC.
Circulation
|October 20, 2025
まとめ
心血管医学は大きな進歩を遂げていますが 実施のギャップが原因で死亡率の減少は停滞しています 将来の取り組みは 予防と新しい治療法への 平等なアクセスを優先しなければなりません
科学分野:
- 心血管医学と技術
- 分子医学
- 医療サービス研究
背景:
- 75年にわたる心臓血管科学の 顕著な進歩により 発病率と死亡率が低下しました
- 1950年から2010年にかけての画期的な革新は 心血管疾患による死亡率の減少に寄与しました
- 最近の進歩には,新しい薬学療法,介入療法,外科技術,分子医学 (遺伝子編集,RNAベースの治療) が含まれる.
研究 の 目的:
- 過去15年間の心臓血管医学の進歩を 調べるため
- 心血管疾患による死亡率の改善が遅れている理由を特定する.
- 心血管医学の進歩のためのロードマップを提案する.
主な方法:
- 心血管医学における科学文献と技術開発のレビュー
- 心血管疾患と死亡率の動向の分析
- 科学と保健医療の実施モデルの検討
主要な成果:
- イノベーションにもかかわらず 心血管疾患による死亡率の改善は停滞しています
- 流行病学的な変化と 継続的な不平等は 停滞した進歩の主要な要因です
- 新しい分子医学のアプローチは有望ですが 効果的な治療が必要です
結論:
- 将来の心臓血管医学の進歩には 革新を超えて 強力な予防戦略を 含めることが必要です
- 責任あるイノベーションと 配慮した医療の提供は 進歩を 人口の健康状態の改善に 変換するために不可欠です
- 心血管医学の進歩からすべての個人が恩恵を受けるためには 健康上の不平等に対処することが不可欠です
関連する概念動画
Coronary Artery Disease V: Interprofessional Care
212
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
212
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Coronary Artery Disease I: Introduction
876
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
876
Cardiomyopathy V: Interprofessional Care
335
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
Regulation of the Cardiovascular System
3.6K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.6K
Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K


